In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: MetLife’s current price at $96.26 is substantially below the high-confidence PERT fair value of $148.65, indicating significant upside potential but with considerable volatility (57.96% coefficient of variation). Financial health scores show fair stability but low efficiency, contributing to downside risk near 30.6%. Monte Carlo results reveal wide valuation dispersion, highlighting high risk alongside substantial growth opportunity.